Directors Talk – Q&A with Michel Baelen, Head of Regulatory Affairs at Advanced Oncotherapy Plc

Article published by Directors Talk  Q&A: Advanced Oncotherapy Plc Michel Baelen, Head of Regulatory Affairs Posted by: giles.arbor 10th May 2017 Michel Baelen,  head of Regulatory Affairs at Advanced Oncotherapy plc  (LON:AVO), talks to DirectorsTalk about the attraction of joining AVO, his past roles and how this experience benefits the company, work done to date […]

Sanjeev Pandya of Advanced Oncotherapy (AVO) interviewed by BRR Media

Sanjeev Pandya, Executive Vice President for Global Business Development for Advanced Oncotherapy (AVO) provides an update to shareholders on development progress of the Company’s novel proton accelerator. Sanjeev also introduces Michel Baelen, the recently appointed Global Head of Regulatory Affairs. Click the image to watch.    

Advanced Oncotherapy (AVO) – Senior Management Appointments

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Michel Baelen has joined the Company as Head of Regulatory Affairs and Gerardo d’Auria has been appointed as a new Technical Director with immediate effect. Michel Baelen holds a Doctorate in management sciences from France and is graduated in Electrical […]